MetaCap

Silence Therapeutics Plc American Depository Share (SLN)

NASDAQ: SLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

19.810.00 (0.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SLN stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$1.05
52-week range
4.19 – 19.87
Day range
19.80 – 19.83
Volume / Avg
399.15K / 2.41M
Beta
—

52-week range

$4.19$19.87

SLN stock today

Silence Therapeutics Plc American Depository Share (SLN) closed at $19.81 on Nov 20, essentially unchanged from the prior close, versus the S&P 500's 3.70% decline. Trading was light, with 399.15K shares changing hands, about 17% of the average daily volume. The stock is trading at or near its 52-week high of $19.87, set on Oct 26, 2026, 372.8% above the 52-week low of $4.19.

SLN is up 225.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 213.9%. Silence Therapeutics Plc American Depository Share has posted a net loss over the last twelve months (EPS of -$1.05), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Silence Therapeutics Plc American Depository Share

Company profile

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D
Headquarters
London
Employees
88

Financial highlights

Full financials

In fiscal 2025, Silence Therapeutics Plc American Depository Share generated $559,000 in revenue, down 98.7% from fiscal 2024, the first decline in the 4 years shown. Silence Therapeutics Plc American Depository Share reported a net loss of $88.6 million, compared with a loss of $45.3 million a year earlier. Gross margin was 61.5% (down from 72.7%) and operating margin -16292.8%.

Silence Therapeutics Plc American Depository Share annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$559.00K$43.26M$31.64M$21.66M
Growth-98.71%+36.71%+46.12%—
Net income$-88.61M$-45.31M$-54.23M$-50.33M
EPS (diluted)$-0.63$-0.33$-0.49$-0.52

Analyst forecast

Forecast

Consensus (5 analysts)

hold

Avg. price target

$19.75-0.30%

  • Strong buy 0
  • Buy 1
  • Hold 4
  • Sell 0
  • Strong sell 0

Target range

Low $19.00High $20.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-0.24 vs $-0.26
Surprise
+7.69%

SLN news

All SLN news

Silence Therapeutics Plc American Depository Share peers

Health Care sector
SLN peer companies
CompanyPrice% ChgMarket capCompare
GENBGenerate Biomedicines Inc.9.54-8.00%$1.23Bvs SLN
MNKDMannKind Corporation3.85-2.53%$1.24Bvs SLN
OCULOcular Therapeutix Inc.5.57-4.95%$1.23Bvs SLN
MLYSMineralys Therapeutics Inc.13.66-3.53%$1.21Bvs SLN
LBRXLB Pharmaceuticals Inc38.85-2.97%$1.26Bvs SLN
AMPHAmphastar Pharmaceuticals Inc.28.25+0.50%$1.20Bvs SLN
GHRSGH Research PLC17.53-5.55%$1.20Bvs SLN
AVLNAvalyn Pharma Inc.28.40-1.05%$1.26Bvs SLN

Indexes, lists and sector

Silence Therapeutics Plc American Depository Share stock FAQ

What is Silence Therapeutics Plc American Depository Share's stock price today?

SLN last traded at $19.81 as of Nov 20, 4:00 PM EST, up 0.00% on the day. Prices are delayed at least 15 minutes.

Who is Silence Therapeutics Plc American Depository Share's CEO?

Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D is the chief executive officer of Silence Therapeutics Plc American Depository Share, which has about 88 employees.

What is the SLN 52-week high?

The 52-week high for SLN is $19.87 and the 52-week low is $4.19. The stock is currently 0.3% below its high.

Compare SLN